1. Home
  2. CCCC vs TII Comparison

CCCC vs TII Comparison

Compare CCCC & TII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.50

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

TII

Titan Mining Corporation

N/A

Current Price

$2.35

Market Cap

205.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CCCC
TII
Founded
2015
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.3M
205.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
TII
Price
$2.50
$2.35
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.4M
73.3K
Earning Date
11-06-2025
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
$30,108,000.00
$75,461,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.41
Revenue Growth
N/A
54.36
52 Week Low
$1.09
$0.26
52 Week High
$4.70
$3.39

Technical Indicators

Market Signals
Indicator
CCCC
TII
Relative Strength Index (RSI) 49.03 N/A
Support Level $2.50 N/A
Resistance Level $2.69 N/A
Average True Range (ATR) 0.18 0.00
MACD -0.01 0.00
Stochastic Oscillator 23.86 0.00

Price Performance

Historical Comparison
CCCC
TII

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About TII Titan Mining Corporation

Titan Mining Corp is a Canadian natural resources company. It is engaged in the acquisition, exploration, and development of mineral properties. The company owns an interest in the Empire State Mine in Northern New York State, United States. The Company operates one reportable segment, mineral production and exploration in the United States.

Share on Social Networks: